jc
jc

News Center

Check category
/
/
/
Shandong Qianfoshan Hospital heart team successfully completed the hospital's first case of apical TAVI surgery

Shandong Qianfoshan Hospital heart team successfully completed the hospital's first case of apical TAVI surgery

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-10-31 13:21
  • Views:

(Summary description)

Shandong Qianfoshan Hospital heart team successfully completed the hospital's first case of apical TAVI surgery

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-10-31 13:21
  • Views:
Information

X

 

X

 

  On October 18, Professor Zhang Haibo, a TAVI team from Beijing Anzhen Hospital, completed the first TAVI billing operation, marking Ahn Jung Hospital as the first hospital to have two independent J-Valve? operators. The patient was a 65-year-old man who was admitted to hospital 2 years earlier after having been active 2 years ago and was diagnosed with severe incomplete closure. (Heart failure process unknown) After the Heart Team discussion, decided to use the J-Valve ? Cheval ? interventional valve TA-TAVI surgery

 

C

 

X

 

  ▌CTA results showed that the aortic valve trefoil type, severe incomplete closure, after evaluation and discussion, the Heart Team decided to choose 27mm J-Valve ? Cheval ? interventional valve
  ▌ surgery director Meng Xu director, director Zhang Haibo chief surgeon in the heart of hybrid surgery room completed, placement of temporary pacing lead via the internal jugular vein. DR to determine the location of apical puncture, 3cm minimally invasive incision. Suspension of the pericardium and purse sack. Femoral artery puncture into the 5F sheath, the whole body to place the Pigtail catheter to the aortic root (ACT> 250s), select the best DR projection angle, access to the best guide section.
  Step 1: Ultrasound and DR-guided apical puncturing, 1.8m J-Tip guide wire into the ascending aorta, vascular sheath, using JR4 catheter guide wire across the aortic arch to the descending aorta, replace 2.6m plus hard guide wire.
  Step 2: Insert the transapical device into the ascending aorta. Release the positioning key, and pulled back to the three aortic valve sinus, angiography confirm the positioning key position is correct.
  Step 3: Retract the valve and the stent valve into the aortic valve area under the guidance of the positioning key.
  Step 4: Rotate the release button, the valve is released (due to the self-expanding valve, the whole process does not require RVP and any haemodynamic fluctuations).
  Step 5: Recycling the implanter to release the valve, angiography and TEE Real valve in good position, without paravalvular leak. Suture apical incision, no bleeding apical, layer by layer incision closure.
  ▌ the entire surgical procedure a total of 20 minutes, the patient recovered well
  ▌J-Valve? Human Interventional Bio-heart Valve is a new generation of interventional valve that was approved by the State Food and Drug Administration for clinical use in May 2017. Its indications include aortic valve stenosis, aortic valve insufficiency and host Aortic valve stenosis with incomplete closure, is currently the world's only officially approved to treat aortic valve regurgitation interventional valve, but also a one-stop solution of aortic valve disease.

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息